Navigating the labyrinth of CSU management
Unable to attend EAACI Congress 2024?
What are the challenges in diagnosis for people with chronic spontaneous urticaria (CSU)? Where are the hurdles throughout the patient journey? And how can emerging treatments help improve outcomes for people with CSU?
Professor Ana Maria Giménez-Arnau (Spain), Professor Simon Francis Thomsen (Denmark) and Professor Martin Metz (Germany) will discuss these key topics during a Novartis-sponsored symposium at the European Academy of Allergy & Clinical Immunology (EAACI) Congress 2024.
Register to access the symposium recording.
Agenda
Navigating the labyrinth of CSU management 1 June 2024 – 12:00 PM – 13:00 CEST |
||
Chair: Ana Maria Giménez-Arnau | ||
12:00 | Welcome address | Ana Maria Giménez-Arnau |
12:05 | Session 1: Demystifying CSU: Diagnostic challenges and practical insights | Simon Francis Thomsen |
12:20 | Session 2: Accelerating the CSU patient journey – Where are the hurdles? | Martin Metz |
12:35 | Session 3: How can novel treatments help streamline CSU management? | Ana Maria Giménez-Arnau |
12:50 | Q&A session | All faculty |
12:55 | Closing statements | Ana Maria Giménez-Arnau |
Don’t miss this opportunity to gain expert perspective on this complex and evolving topic
Faculty
Professor Ana Maria Giménez-Arnau
Ana Maria Giménez-Arnau is Associate Professor of Dermatology at Pompeu Fabra University, Barcelona, Spain. She is also a consultant physician in dermatology and venereology at the Hospital del Mar, Barcelona, Spain. Her main scientific areas of interest are urticaria, eczema, contact dermatitis and atopic dermatitis.
Disclosures: Honoraria as a speaker and/or consultant: Almirall, Amgen, AstraZeneca, Avène, Celldex, Escient Pharmaceuticals, Genentech, GSK, Instituto Carlos III-FEDER, Leo Pharma, Menarini, Mitsubishi Tanabe Pharma, NOUCOR, Novartis, Sanofi‑Regeneron, Servier, Thermo Fisher Scientific, and Uriach.
Professor Martin Metz
Martin Metz is Professor of Dermatology at the Institute of Allergology at Charité–Universitätsmedizin Berlin, Germany, and at the Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Allergology and Immunology. His main scientific areas of interest are mast cell biology, neuroimmunology, inflammation and innate immunity. He has a major clinical and translational focus on pruritus and mast cell-mediated diseases.
Disclosures: Honoraria as a speaker and/or consultant: AbbVie, Almirall, Amgen, argenx, AstraZeneca, Bayer, Beiersdorf, Celldex Therapeutics, Celltrion, Escient Pharmaceuticals, Galderma, GSK, Jasper Therapeutics, Novartis, Pfizer, Pharvaris, Sanofi, Teva Pharmaceuticals, Third Harmonic Bio, and Vifor Pharma.
Professor Simon Francis Thomsen
Simon Francis Thomsen is a dermatologist and professor at the Department of Dermatology, Bispebjerg Hospital, Copenhagen, Denmark. His research focuses on the aetiology, clinical course and treatment of chronic inflammatory skin diseases, particularly chronic urticaria.
Disclosures: Research support: Janssen, LEO Pharma, Novartis, Sanofi, and UCB. Speaker/consultant: AbbVie, Almirall, Eli Lilly, Galderma, Incyte, Janssen, LEO Pharma, Novartis, Pfizer, Sanofi, Symphogen, UCB, and Union Therapeutics.
Developed by EPG Health in collaboration with the sponsor, Novartis Pharma AG. EPG Health received education funding from the sponsor in order to provide healthcare professionals access to medical and scientific information, education and associated content; which is non promotional and not intended to endorse or promote any specific pharmaceutical product. Prescribing information may vary depending on local health authority approval in each country. Before prescribing any product, always refer to the SmPC or product information approved in your country. 434324, April 2024.